SCIENTIFIC BACKGROUND

DMPK

Category:

Myotonic dystrophies are multisystemic diseases with an autosomal dominant inheritance pattern that represent the most common muscular dystrophies in adults. The prevalence of myotonic dystrophy type 1 (DM1) is estimated at 1:8,000. Onset of symptoms, such as myotonia characterized by delayed relaxation of a tense muscle, is most often observed in early adulthood. In addition, there is muscle weakness and fatigue, as well as dysphagia, an elongated face with poor facial expression, cataracts, diabetes mellitus, and cardiac arrythmias; in men there is early development of a bald forehead and testicular atrophy. The clinical presentation of DM1 is categorized into four partially overlapping phenotypes: asymptomatic, mild, classic, and neonatal. The congenital form is characterized by pronounced muscle hypotonia, often clubfoot formation, and is usually associated with respiratory insufficiency difficulty drinking. Psychomotor development is often delayed. This type occurs predominantly when the disease is passed down from the mother and only in DM1.

 

DM1 is caused by a CTG repeat expansion in the non-translated 3' region of the DMPK gene on chromosome 19 which encodes a protein kinase. DM2 (proximal myotonic myopathy), which is important for differential diagnosis, is caused by expansion of a CCTG repeat in intron 1 of the ZNF9 gene on chromosome 3. The phenomenon of anticipation—meaning a decrease in the age of onset of the disease and/or an increase in the severity of symptoms from one generation to the next—is particularly pronounced in DM1. Healthy individuals have 5-36 CTG repeats in the DMPK gene while DM patients have up to approximately 1,000. Children with the congenital type have more than 1,000 repeats.

 

References

Ashizawa et al. 2018, Neurol Clin Pract 8:507 / Pratte et al. 2015, Am J Med Genet A 167A:708 / Turner et al. 2010, J Neurol Neurosurg Psychiatry 81:358 / Schara et al. 2006, Semin Pediatr Neurol 13:71  / Ranum et al. 2004, Am J Hum Genet 74:793 / Larkin et al. 2001, Brain Res Bull 56:389

GENES

DMPK

ASSOCIATED TESTS

How to order

LATEST ARTICLES

In May 2024, the American Society of Clinical Oncology (ASCO) published new guidelines for germline genetic testing in patients with cancer (1). ...

Read more

Genetics as we know and understand it today has been shaped, over decades, by the work of many dedicated scientists around the world, and they all de...

Read more

A comprehensive single-cell transcriptomic atlas of 1.3 million cells from aged human brains reveals cellular pathways linked to Alzheimer’s diseas...

Read more

Infertility is a struggle for many individuals nowadays. According to the World Health Organization (WHO), 1 in 6 people experience infertility, show...

Read more

A recent study highlights promising outcomes for BRCA variant carriers with breast cancer undergoing breast-conserving therapy. Analyzing 172 women, ...

Read more

Epidermolysis bullosa (EB), sometimes called butterfly skin, is a group of rare skin diseases with a common symptom: fragile skin that tears and blis...

Read more

In the rapidly evolving field of human genetics diagnostics, laboratories face the challenge of keeping up with the latest advancements in technology...

Read more

Medicine as we know it has been around for just over 100 years. Before this, alcohol and opium were the main forms of pain relief in Europe. The deve...

Read more

Below you can read the two winning essays from the second annual DNA essay competition. The subject of the essay was “Family history is one of the ...

Read more

Mosaicism is the presence of two or more genetically different sets of cells within the same person. It is a biological phenomenon that may have no e...

Read more